Short Summary
The PTAB instituted an inter partes review of Inari Medical’s 11,844,921 B2 hemostasis valve patent after Imperative Care showed a reasonable likelihood of success on multiple claims. The dispute centers on the definition of “filament” and reliance on prior art Schaffer, Hartley, and Eller.
Detailed Summary
In a Decision Granting Institution of Inter Partes Review, the Patent Trial and Appeal Board found that Imperative Care, Inc. demonstrated a reasonable likelihood of prevailing on at least one of the claims of Inari Medical’s ’921 patent covering hemostasis valves for minimally invasive vascular surgery. The petition challenged claims 1‑7, 9, 10, 15‑18, and 20‑24 under §§102 and 103, relying on prior art references Schaffer, Hartley, and Eller. A key issue was whether the term “filament” required flexibility; the Board preliminarily leaned toward the patent owner’s view that it does. Based on the record, the Board instituted review on all 19 challenged claims, setting the stage for a full trial on obviousness and anticipation arguments.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Imperative Care, Inc. vs Inari Medical, Inc. et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Meta Platforms, Inc.vsDialect, LLC
The USPTO denied institution for IPR2025-01336 after reviewing the merits. The petitioner failed to meet the standard of showing a reasonable likelihood of prevailing on at least one challenged claim.
Samsung Electronics Co. Ltd. et al.vsMaxell, Ltd.
The USPTO Board granted institution for IPR2025-01315 after determining the petitioner had a reasonable likelihood of prevailing on at least one challenged claim. The decision is part of a larger notice covering multiple institution decisions across various proceedings.
Dell Technologies Inc. et al.vsLiTL LLC
Petitioners successfully convinced the PTAB to institute review of U.S. Patent No. 9,563,229, challenging claims related to portable computing and orientation sensing. The grounds assert that various combinations of prior art references render the claimed features obvious under 35 U.S.C. § 103.
SAMSUNG ELECTRONICS CO., LTD. et al.vsOMNI MEDSCI, INC.
Apple’s inter‑partes review of Omni MedSci’s ’533 patent resulted in the PTAB finding all challenged claims unpatentable for obviousness over Lisogurski, Carlson, and Mannheimer.
AROMA 360, LLCvsAir Esscentials, Inc.
AROMA 360, LLC successfully petitioned to challenge claims of Air Esscentials, Inc.'s patent (10583449) before the PTAB. The Board found a reasonable likelihood of prevailing on multiple grounds, leading to institution of the IPR.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.